计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| L127607-5mg |
5mg |
现货 ![]() |
| |
| L127607-10mg |
10mg |
现货 ![]() |
| |
| L127607-25mg |
25mg |
现货 ![]() |
| |
| L127607-50mg |
50mg |
现货 ![]() |
| |
| L127607-100mg |
100mg |
现货 ![]() |
|
| 别名 | 索格列净 |
|---|---|
| 英文别名 | A852129 | Sotagliflozin (LX4211) | Sotagliflozin (LX-4211) | 1018899-04-1 | Tox21_501139 | UNII-6B4ZBS263Y | (2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-tetrahydro-6-(methylthio)-2H-pyran-3,4,5-triol;LX4211 | DTXSID20144314 | SOTAGLIFLOZIN [MI] |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | LX-4211 |
| 生化机理 | LX-4211 是一种 SGLT2/1 双重抑制剂;抗糖尿病药。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 钠/葡萄糖共转运体 2 抑制剂 |
| 产品介绍 |
LX-4211是SGLT1/2抑制剂,是抗糖尿病剂。 Sotagliflozin (LX4211, LP-802034)是一种双重SGLT1/SGLT2抑制剂,IC50分别为 36 nM 和 1.8 nM。 LX-4211 is a potent dual SGLT2/1 inhibitor; Antidiabetic agents. |
| 纯度 | ≥98% |
| ALogP | 3.2 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504769865 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol |
| INCHI | 1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1 |
| InChi Key | QKDRXGFQVGOQKS-CRSSMBPESA-N |
| Smiles | CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)SC)O)O)O)Cl |
| Isomeric SMILES | CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O)Cl |
| 分子量 | 424.94 |
| Reaxy-Rn | 21494945 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=21494945&ln= |
| 溶解性 | DMSO |
|---|---|
| 分子量 | 424.900 g/mol |
| XLogP3 | 3.200 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 6 |
| 可旋转键计数Rotatable Bond Count | 6 |
| 精确质量Exact Mass | 424.111 Da |
| 单同位素质量Monoisotopic Mass | 424.111 Da |
| 拓扑极表面积Topological Polar Surface Area | 104.000 Ų |
| 重原子数Heavy Atom Count | 28 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 476.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 5 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS08 |
|---|---|
| 信号词 | 警告 |
| 1. Zambrowicz B, Freiman J, Brown PM, Frazier KS, Turnage A, Bronner J, Ruff D, Shadoan M, Banks P, Mseeh F et al.. (2012) LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.. Clin Pharmacol Ther, 92 (2): (158-69). [PMID:22739142] |
| 2. Lapuerta P, Zambrowicz B, Strumph P, Sands A. (2015) Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor.. Diab Vasc Dis Res, 12 (2): (101-10). [PMID:25690134] |